In normal rats, amylin induced an increase in bone formation rate and reduced osteoclast surface and erosive surface in the femur, in type-2 diabetic rats amylin normalized trabecular structure parameters and increased osteoblast number, whereas in insulin-resistant rats amylin appeared to have no osteogenic effects (82). The gene discussed is IAPP; the disease is type 2 diabetes mellitus.